Table 4 Baseline characteristic and mortality outcome measures. Categorical variables are presented as counts (%), and continuous variables are presented as medians [inter-quartile range Q1-Q3]

General

Admissions

6927

1350

5577

Age

65.0 [53.0,77.0]

71.0 [58.0,81.0]

64.0 [52.0,75.0]

Gender (Female)

2853 (41.2%)

602 (44.6%)

2251 (40.4%)

First SOFA

6.0 [4.0,8.0]

8.0 [5.0,11.0]

5.0 [4.0,8.0]

First SAPS

21.0 [18.0,25.0]

24.0 [21.0,28.0]

21.0 [18.0,24.0]

First SAPS II

41.0 [32.0,52.0]

53.0 [44.0,64.0]

39.0 [31.0,49.0]

Origin

Elective

1269 (18.3%)

64 (4.7%)

1205 (21.6%)

Emergency

5463 (78.9%)

1237 (91.6%)

4226 (75.8%)

Urgent

195 (2.8%)

49 (3.6%)

146 (2.6%)

Site

MICU

1974 (28.5%)

600 (44.4%)

1374 (24.6%)

SICU

1359 (19.6%)

266 (19.7%)

1093 (19.6%)

CCU

660 (9.5%)

163 (12.1%)

497 (8.9%)

CSRU

1599 (23.1%)

98 (7.3%)

1501 (26.9%)

TSICU

1335 (19.3%)

223 (16.5%)

1112 (19.9%)

Lab Results

HR (BPM)

88.0 [76.0,102.0]

92.0 [78.0,109.0]

87.0 [76.0,100.0]

NBP (MMHG)

113.0 [100.0,130.0]

109.0 [95.0,127.0]

114.0 [101.0,129.0]

RR (CPM)

20.56 [17.71-23.88]

20.78 [17.90-24.19]

20.31 [17.57-23.53]

NA (MMOL/L)

139.0 [137.0,142.0]

140.0 [136.0,143.0]

139.0 [137.0,142.0]

K (MMOL/L)

4.1 [3.8,4.6]

4.2 [3.7,4.7]

4.1 [3.8,4.6]

HCO3 (MMOL/L)

23.0 [19.0,25.0]

21.0 [17.0,24.0]

23.0 [20.0,26.0]

WBC (103/MM3)

11.7 [8.2,16.1]

12.3 [7.5,17.8]

11.7 [8.4,15.8]

P/F Ratio

235.13 [227.10-235.13]

235.13 [207.50-235.23]

235.13 [235.13-235.13]

Ht (%)

28.40 [25.00-32.30]

27.90 [24.40-31.70]

29.10 [25.80-32.70]

Urea (mmol/l)

77.79 [46.35-120.52]

70.27 [34.77-94.43]

104.25 [60.69-140.53]

Bilirubin (mg/dl)

1.00 [0.50-2.36]

1.25 [0.50-2.88]

0.88 [0.45-1.66]

Outcomes

ICU LOS (days)

4.7 [2.4,10.5]

5.7 [2.7,11.7]

4.5 [2.3,10.2]

ICU Death (%)

1129 (16.3%)

1129 (83.6%)

-

Hospital Death (%)

1350 (19.5%)

1350 (100%)

-